Revolution Medicines Valuation
| RVMD Stock | USD 57.50 0.75 1.32% |
At this time, the company appears to be overvalued. Revolution Medicines holds a recent Real Value of $51.93 per share. The prevailing price of the company is $57.5. Our model determines the value of Revolution Medicines from analyzing the company fundamentals such as Current Valuation of 8.08 B, shares owned by insiders of 2.13 %, and Return On Equity of -0.47 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Revolution Medicines' valuation include:
Price Book 6.0949 | Enterprise Value 8.1 B | Enterprise Value Ebitda (9.71) | Price Sales 12.9 K | Enterprise Value Revenue 10.9 K |
Overvalued
Today
Please note that Revolution Medicines' price fluctuation is very steady at this time. Calculation of the real value of Revolution Medicines is based on 3 months time horizon. Increasing Revolution Medicines' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Revolution stock is determined by what a typical buyer is willing to pay for full or partial control of Revolution Medicines. Since Revolution Medicines is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Revolution Stock. However, Revolution Medicines' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 57.5 | Real 51.93 | Target 36.0 | Hype 58.08 | Naive 53.55 |
The real value of Revolution Stock, also known as its intrinsic value, is the underlying worth of Revolution Medicines Company, which is reflected in its stock price. It is based on Revolution Medicines' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Revolution Medicines' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Revolution Medicines helps investors to forecast how Revolution stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Revolution Medicines more accurately as focusing exclusively on Revolution Medicines' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Revolution Medicines' intrinsic value based on its ongoing forecasts of Revolution Medicines' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Revolution Medicines' closest peers. If more than one evaluation category is relevant for Revolution Medicines we suggest using both methods to arrive at a better estimate.
Revolution Medicines Cash |
|
Revolution Valuation Trend
Comparing Revolution Medicines' enterprise value against its market capitalization is a good way to estimate the value of Revolution Medicines uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Revolution Medicines Total Value Analysis
Revolution Medicines is at this time expected to have valuation of 8.08 B with market capitalization of 9.55 B, debt of 87.94 M, and cash on hands of 461.43 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Revolution Medicines fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.08 B | 9.55 B | 87.94 M | 461.43 M |
Revolution Medicines Investor Information
About 98.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.66. Revolution Medicines had not issued any dividends in recent years. Based on the key indicators related to Revolution Medicines' liquidity, profitability, solvency, and operating efficiency, Revolution Medicines is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Revolution Medicines Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Revolution Medicines has an asset utilization ratio of 0.56 percent. This indicates that the Company is making $0.005617 for each dollar of assets. An increasing asset utilization means that Revolution Medicines is more efficient with each dollar of assets it utilizes for everyday operations.Revolution Medicines Ownership Allocation
The majority of Revolution Medicines outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Revolution Medicines to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Revolution Medicines. Please pay attention to any change in the institutional holdings of Revolution Medicines as this could imply that something significant has changed or is about to change at the company.Revolution Medicines Profitability Analysis
The company reported the previous year's revenue of 11.58 M. Net Loss for the year was (436.37 M) with loss before overhead, payroll, taxes, and interest of (217.69 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Revolution Medicines' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Revolution Medicines and how it compares across the competition.
About Revolution Medicines Valuation
The stock valuation mechanism determines Revolution Medicines' current worth on a weekly basis. Our valuation model uses a comparative analysis of Revolution Medicines. We calculate exposure to Revolution Medicines's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Revolution Medicines's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -399.7 M | -379.7 M | |
| Pretax Profit Margin | (37.99) | (36.09) | |
| Operating Profit Margin | (42.07) | (39.97) | |
| Net Loss | (37.68) | (35.80) | |
| Gross Profit Margin | (34.51) | (32.79) |
Revolution Medicines Growth Indicators
Investing in growth stocks can be very risky. If the company such as Revolution Medicines does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 113.1 M |
Revolution Medicines Current Valuation Indicators
Valuation refers to the process of determining the present value of Revolution Medicines and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Revolution we look at many different elements of the entity such as Revolution's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Revolution Medicines, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Revolution Medicines' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Revolution Medicines' worth.Complementary Tools for Revolution Stock analysis
When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |